A drug that would be the first to target the cause of Huntington’s disease is effective and safe when tested in mice and monkeys, according to data released today that will be presented at the American Academy of Neurology’s 68th Annual Meeting in Vancouver, Canada, April 15-21, 2016. A study to test the drug in humans has begun.